Gohealth Inc GOCO.OQ GOCO.O is expected to show a rise in quarterly revenue when it reports results on August 6 (estimated) for the period ending June 30 2025
The Chicago Illinois-based company is expected to report a 8.2% increase in revenue to $114.514 million from $105.87 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
‚ÄãLSEG's mean analyst estimate for Gohealth Inc is for a loss of $2.58 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months. ‚Äã
Wall Street's median 12-month price target for Gohealth Inc is $23.00, about 75.8% above its last closing price of $5.56
Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äã
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.25
-0.29
-0.52
Missed
-76.9
Dec. 31 2025
1.30
1.16
2.19
Beat
88.3
Sep. 30 2024
-3.29
-3.19
0.46
Beat
114.4‚Äã
Jun. 30 2024
-2.36
-2.47
-2.70
Missed
-9.2
​​Mar. 31 2024
-0.96
-0.95
-1.04
Missed
-9.1
Dec. 31 2023
2.74
2.73
-0.22
Missed
-108.1‚Äã
Sep. 30 2023
-2.90
-2.90
-2.61
Beat
10
Jun. 30 2023
-2.33
-2.92
-3.27
Missed
-12.1
This summary was machine generated August 4 at 14:22 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)